- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03844672
Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns
December 11, 2023 updated by: Tracy Smith, Medical University of South Carolina
Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns Among
The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes.
Participants will receive an e-cigarette to sample over a three week period.
During this time period they will complete daily electronic diaries and weekly lab visits.
The results from this information will help understand how different types of e-cigarettes are likely to influence cigarette and e-cigarette use.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tracy Smith, PhD
- Phone Number: 843-792-5164
- Email: smithtra@musc.edu
Study Contact Backup
- Name: Matt Carpenter, PhD
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria include
- adults who have been smoking daily
- interested in using e-cigarettes
- who have a smartphone that can receive text messages and access to the internet or has an e-mail account that they check daily
Exclusion criteria include
- minimal prior e-cigarette use
- use of tobacco products other than cigarettes
- current use of cessation medications
- pregnant, trying to become pregnant, or breastfeeding,
- recent history of cardiovascular distress in the last three months (e.g., arrhythmia, heart attack, stroke, uncontrolled hypertension),
- household member currently enrolled in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low Concentration / Low Power
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a low power for three weeks.
|
Participants will receive a low power e-cigarette to use for 3 weeks
Participants will receive a low concentration e-liquid to use for 3 weeks
|
Experimental: Low Concentration / High Power
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a high power for three weeks.
|
Participants will receive a low concentration e-liquid to use for 3 weeks
Participants will receive a high power e-cigarette to use for 3 weeks
|
Experimental: High Concentration / Low Power
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a low power for three weeks.
|
Participants will receive a low power e-cigarette to use for 3 weeks
Participants will receive a high concentration e-liquid to use for 3 weeks
|
Experimental: High Concentration / High Power
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a high power for three weeks.
|
Participants will receive a high power e-cigarette to use for 3 weeks
Participants will receive a high concentration e-liquid to use for 3 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Cigarettes Per Day
Time Frame: up to 3 weeks
|
Participants complete daily electronic diaries reporting the number of cigarettes smoked each day on a continuous scale
|
up to 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Number of E-cigarette Puffing Episodes
Time Frame: up to 3 Weeks
|
Participants complete daily electronic diaries reporting the number of e-cigarette puffing episodes each day on a continuous scale
|
up to 3 Weeks
|
Number of Choices to Smoke Cigarette in Lab Setting
Time Frame: Week 3
|
Participants complete lab-based choice task at Week 3 visit in which they choose between smoking conventional cigarette and e-cigarette over 10 trials.
Outcome is number of times each participant chooses to smoke conventional cigarette.
|
Week 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Tracy Smith, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2019
Primary Completion (Actual)
October 17, 2023
Study Completion (Actual)
November 9, 2023
Study Registration Dates
First Submitted
February 14, 2019
First Submitted That Met QC Criteria
February 14, 2019
First Posted (Actual)
February 18, 2019
Study Record Updates
Last Update Posted (Estimated)
December 12, 2023
Last Update Submitted That Met QC Criteria
December 11, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 00081069
- K01DA047433 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); University of Massachusetts, WorcesterRecruiting
Clinical Trials on Low Power
-
Youngstown State UniversityCompleted
-
University of Sao Paulo General HospitalCompletedOsteoarthritisBrazil
-
Tufts UniversityCompleted
-
Cairo UniversityCompleted
-
University of California, IrvineMassachusetts General Hospital; Beckman Laser Institute University of California...CompletedVaccine Response ImpairedUnited States
-
CochlearAvaniaNot yet recruitingHearing Loss, SensorineuralAustralia
-
Landstuhl Regional Medical CenterCompleted
-
Chang Gung Memorial HospitalCompletedMyofacial Pain SyndromesTaiwan
-
Uppsala UniversityUnknownChemotherapy Induced Peripheral Neuropathy (CIPN)Sweden
-
Instituto Nacional de Cancer, BrazilRecruitingStomatitis | Hematopoietic Stem Cell Transplantation | Low-Level Light TherapyBrazil